Treatment of complement-associated disorders

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S144100, C424S809000, C424S810000, C514S002600

Reexamination Certificate

active

10964263

ABSTRACT:
The present invention concerns a recently discovered macrophage specific receptor, STIgMA, and its use in the treatment of complement-associated disorders.

REFERENCES:
patent: 6410708 (2002-06-01), Askenazi et al.
patent: 7192589 (2007-03-01), Ashkenazi et al.
patent: WO 99/27098 (1999-06-01), None
patent: WO 99/40100 (1999-08-01), None
patent: WO 00/12703 (2000-03-01), None
patent: WO 00/29583 (2000-05-01), None
patent: WO 00/36102 (2000-06-01), None
patent: WO 00/37638 (2000-06-01), None
patent: WO 00/53758 (2000-09-01), None
patent: WO 01/04311 (2001-01-01), None
patent: WO 01/36432 (2001-05-01), None
patent: WO 01/40466 (2001-06-01), None
patent: WO 02/00690 (2002-01-01), None
patent: WO 02/08284 (2002-01-01), None
patent: WO 02/08284 (2002-01-01), None
Rudikoff, S et al. Proc Natl Acad Sci USA [1982] 79:1979-1983.
MacCallum, RM et al. J. Mol. Biol. [1996] 262:732-745.
Casset, F et al. Biochem. Biophys. Res. Comm. [2003] 307:198-205.
Wu, H etal. J. Mol. Biol. [1999] 294:151-162.
Martin-Padura et al., “Junctional Adhesion Molecule , A Novel Member of the Immunoglobin Superfamily that Distributes at Intercellular Junctions and Modulates Monocyte Transmigration”, J. Cell Biology, vol. 142, No. 1, pp. 117-127, Jul. 13, 1998.
Ozaki et al, “Cutting Edge: Combined Treatment of the TNF-alpha and IFN-gamma causes Redistribution of Junctional Adhesion Molecule in Human Endothelial Cells”, J. Immunol., vol. 163, No. 2, Jul. 15, 1999.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of complement-associated disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of complement-associated disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of complement-associated disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3956010

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.